Why is Jubilant Pharmo falling/rising?

As of 07-Jul, Jubilant Pharmova Ltd is currently priced at 1,194.60, reflecting a decrease of 3.8 points or 0.32%. The stock has been experiencing a decline, having fallen for the last two consecutive days with a total return of -0.37% during this period. Despite touching an intraday high of Rs 1232.85 earlier in the day, the stock's performance has been impacted by a significant drop in delivery volume, which fell by 38.72% compared to the 5-day average. While the stock has shown strong long-term performance with a 59.12% return over the past year, it has also faced challenges, including a negative annual growth rate in net sales and operating profit over the last five years.
In the broader market context, the stock's short-term performance has underperformed relative to the benchmark, with a 1-week return of -1.21% compared to the Sensex's decline of only -0.20%. This suggests that while Jubilant Pharmova has shown strong long-term growth and positive financial metrics, such as a high return on capital employed and low debt-equity ratio, its recent price movement has been negatively influenced by declining investor participation and short-term volatility. The stock's liquidity remains adequate for trading, but the recent downward trend may raise concerns among investors, particularly in light of the company's mixed long-term growth indicators.